Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

about

Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent.Tocilizumab for the Treatment of Mevalonate Kinase Deficiency

P2860

Q40105382-32D03C79-5CD4-4CD3-BC59-28AC38A582D5 Q58702054-97B73056-042C-4957-8776-4D18F3D98C90

P2860

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

Item

http://www.wikidata.org/entity/Q43184639

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@en

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@nl

type

Item

label

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@en

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@nl

prefLabel

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@en

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@nl

P1476

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

@en

P2093

Anne Musters

http://www.w3.org/2001/XMLSchema#string

Dominique L P Baeten

http://www.w3.org/2001/XMLSchema#string

Paul Peter Tak

http://www.w3.org/2001/XMLSchema#string

Sander W Tas

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils

Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology.

Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.

Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.

The function and regulation of immunoglobulin D.

Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.

TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.

P31

scholarly article

P356

10.1136/BCR-2015-210513

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26516243

http://www.w3.org/2001/XMLSchema#string

P932

4636692

http://www.w3.org/2001/XMLSchema#string

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

about

P2860

P2860

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P478

P577

P698

P932